India Insulin Delivery Devices Market to grow with a CAGR of 7.90% through 2030

According to TechSci Research report, “India Insulin Delivery Devices Market- By Region, Competition, Forecast and Opportunities, 2020-2030F”, India Insulin Delivery Devices Market has valued at USD 1.06 billion in 2024 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 7.90 % through 2030.  The rising prevalence of diabetes is a key driver of growth in the India insulin delivery devices market. With an increasing number of both Type 1 and Type 2 diabetes cases, there is a growing demand for effective and efficient management solutions, particularly insulin therapy. According to the WHO, approximately 77 million people over 18 years old in India are affected by Type 2 diabetes, with nearly 25 million at high risk of developing the disease. More than 50% of individuals remain unaware of their condition, leading to complications if not addressed early. Contributing factors include sedentary lifestyles, poor diets, and stress, which are accelerating the rise in Type 2 diabetes, especially among adults. As the diabetic population grows, the demand for insulin therapy and by extension, insulin delivery devices continue to increase.

Insulin therapy is essential, particularly for those with Type 1 diabetes or advanced-stage Type 2 diabetes, who can no longer produce adequate insulin naturally. This escalating need for insulin therapy drives the demand for delivery devices like insulin pens, auto-injectors, pumps, and needle-free injectors, ensuring accurate and convenient insulin administration. Growing awareness of the importance of diabetes management is encouraging patients to seek out insulin delivery devices that provide convenience and improved outcomes. The shift toward self-management of diabetes, with a focus on regular insulin administration, is fueling demand for self-administration devices like insulin pens and auto-injectors, enabling patients to manage their condition at home without frequent healthcare visits.

As diabetes cases increase, India is enhancing its healthcare infrastructure, facilitating better access to insulin delivery devices through retail pharmacies, medical device retailers, and online platforms. Government initiatives to improve healthcare access, particularly in rural and underserved areas, are further boosting device availability. There is a growing trend among diabetic patients to manage their condition independently. Insulin delivery devices such as pens and pumps, which offer ease of use, accuracy, and less discomfort, are encouraging greater patient compliance and self-administration. Diabetes is a chronic condition that requires lifelong management. The ongoing need for insulin therapy and effective delivery systems plays a crucial role in driving the market for insulin delivery devices. With the rising prevalence of diabetes, especially in India’s aging population, the demand for insulin delivery devices is expected to continue growing. Older adults, who are more likely to develop diabetes, also require insulin therapy, further increasing the need for user-friendly devices such as insulin pens and pumps, which provide consistent and reliable results. 

Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " India Insulin Delivery Devices Market”

India Insulin Delivery Devices Market is segmented based on product type, end user, distribution channel, regional distribution, and company.

Based on the End User, the Hospitals & Clinics emerged as dominating segment in the India Insulin Delivery Devices Market in 2024. Hospitals and clinics, particularly those with specialized diabetes care units and endocrinology departments, are well-equipped to offer comprehensive diabetes care. They possess the requisite expertise and infrastructure to diagnose, treat, and manage diabetes, including the utilization of insulin delivery devices. These healthcare facilities provide a range of services, catering to both inpatient and outpatient needs. For patients requiring acute care or those with severe diabetes, hospitals serve as the primary access point for insulin therapy. Similarly, clinics offer essential outpatient care, including the management of insulin therapy. Hospitals and clinics boast multidisciplinary teams comprising endocrinologists, diabetologists, and diabetes educators who specialize in diabetes care. These professionals are instrumental in prescribing and overseeing the use of insulin delivery devices, ensuring optimal treatment outcomes. These healthcare settings are equipped with the necessary medical infrastructure and equipment for diabetes treatment, encompassing the safe storage and administration of insulin. Additionally, hospitals and clinics offer diagnostic services, such as laboratory tests and continuous glucose monitoring, to monitor patients' diabetes management effectively. This facilitates informed decision-making regarding the appropriate utilization of insulin and insulin delivery devices.

Based on the region, the South India emerged as the fastest growing region in the India Insulin Delivery Devices Market during the forecast period. South India, particularly in states such as Tamil Nadu, Andhra Pradesh, Karnataka, and Kerala, has a high prevalence of diabetes, driving significant demand for insulin delivery devices. Cities like Bengaluru, Chennai, and Hyderabad host prominent medical institutions, hospitals, and research centers, fostering the adoption of advanced diabetes management solutions, including insulin delivery devices. The region has also seen a rise in the use of modern healthcare technologies, such as insulin pumps, pens, and auto-injectors, fueled by a tech-savvy population and a robust medical device manufacturing sector. With an increasing trend toward self-management of diabetes, particularly in urban and semi-urban areas, insulin delivery devices like pens and auto-injectors are becoming the preferred choice for home-based management. Government initiatives to improve healthcare access, combined with the strong presence of pharmaceutical and medical device companies, further accelerate the growth of insulin delivery devices in South India. These factors make South India the fastest-growing region in India’s insulin delivery devices market.

Some of the major companies operating in the India Insulin Delivery Devices Market include:

• Biocon Limited
• India Medtronic Pvt. Ltd.
• Roche Products (India) Pvt. Ltd.
• Becton Dickinson India Private Limited
• Novo Nordisk India Pvt Ltd
• Sanofi Healthcare India Pvt. Ltd.
• Eli Lilly & Co (India) Pvt. Ltd
• Abbott India Ltd
• B. Braun Medical SE

Download Free Sample Report

Customers can also request 10% free customization on this report

“The growing aging population, evolving lifestyles, and increasing urbanization have significantly heightened the demand for efficient and convenient insulin administration solutions. Insulin pens, pumps, and auto-injectors are gaining traction for their ease of use and accuracy, enabling patients to independently manage their condition. Government initiatives and the expansion of healthcare infrastructure are further driving the adoption of these devices. As the market grows, there is a strong emphasis on making insulin delivery devices more cost-effective, ensuring wider accessibility, particularly in rural and semi-urban areas, to reach a larger segment of the population,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

"India Insulin Delivery Devices Market By Product Type (Pens, Pumps, Pen Needles, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By End User (Hospitals & Clinics, Homecare, Others), By Region, Competition, Forecast and Opportunities, 2020-2030F”, has evaluated the future growth potential of India Insulin Delivery Devices Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in India Insulin Delivery Devices Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com